ABSTRACT
The investigation of the hemostasis system performed in 47 patients with mechanical heart valves (MHV) at the terms of (3.50 +/- 0.25) years included 30 men and 17 women. There were 24 cases of aortal MHV and 23 cases of mitral MHV, I-II functional class (NYHA). The patients were given oral anticoagulants: phenylin to 35 patients (0.009 mg/day), varfarin to 12 patients (52.6 mg/a week). The primary examination of the patients has revealed insufficient anticoagulation protection and clinically asymptomatic permanent intravascular coagulation of the third degree (PIC-3), with the signs of activation of thrombocytic and/or coagulation link of hemostasis. It has been found that a complex assessment of the hemostasis system state including the vascular-thrombocytic link is an obligatory condition of the right choice and timely correction of the PIC-3 in patients with MHV. The methods of correction of impaired hemostasis depend on the primary involvement of the vascular-thrombocytic and/or coagulation link of hemostasis. The pathogenetically selected antithrombotic therapy for patients with MHV allows timely arrest of PIC-3 and less risk of the development of thrombosis and thrombo-embolic complications at long-term periods of observation.
Subject(s)
Blood Coagulation/drug effects , Fibrinolytic Agents/therapeutic use , Heart Valve Prosthesis/adverse effects , Thromboembolism/blood , Thromboembolism/drug therapy , Ticlopidine/analogs & derivatives , Aspirin/therapeutic use , Clopidogrel , Drug Therapy, Combination , Female , Follow-Up Studies , Humans , Male , Nadroparin/therapeutic use , Platelet Aggregation Inhibitors/therapeutic use , Thromboembolism/etiology , Ticlopidine/therapeutic use , Treatment OutcomeABSTRACT
The observation included 40 patients (20 men and 20 women) with the rheumatic heart diseases acquired at the age of (45.9 +/- 8.7) years after isolated prostheses of the aortal (n = 25) and mitral (n = 15) valves with bicuspid constructions of AHV "MedInzh-2" in remote terms in (2.52 +/- 0.48) years, I-II functional valve (NYHA). It was shown that only a permanent control not rarer than once a month and an adequate correction by means of anticoagulation and antiaggregation therapy using standard methods for patients with the bicuspid AHV made it possible to avoid the development of thromboses and thromboembolic complications during three years of observation.
Subject(s)
Mitral Valve Stenosis/therapy , Pacemaker, Artificial , Thromboembolism/therapy , Thrombosis/therapy , Female , Follow-Up Studies , Humans , Male , Middle Aged , Mitral Valve Stenosis/prevention & control , Thromboembolism/prevention & control , Thrombosis/prevention & controlABSTRACT
An examination of 153 patients with valve replacement was performed at late stages of (6.8 +/- 0.2) years, in 84 patients the mitral valve replacement (MVR) was fulfilled, in 64--the aortic replacement (AVR) and in 5--two valve replacement were performed. Higher indices of hemolysis were noted in patients with AVR, in cases of two valve replacement and in patients with the paravascular fistula. The lowest indices of hemolysis take place in patients with bileaflet prostheses (MEDING/CarboMedics, St. Jude Medical), especially in patients with AVR. The complications of intravascular hemolysis are: cholelithiasis, anemia, hemosiderosis of the kidneys, sideropenia. The timely diagnosis, treatment and prophylactics are necessary to prevent these complications.
Subject(s)
Aortic Valve , Haptoglobins/analysis , Heart Valve Prosthesis/adverse effects , Hemolysis , L-Lactate Dehydrogenase/blood , Mitral Valve , Anemia/diagnosis , Anemia/etiology , Cholelithiasis/diagnosis , Cholelithiasis/etiology , Chronic Disease , Follow-Up Studies , Hemosiderosis/diagnosis , Hemosiderosis/etiology , Humans , Iron Deficiencies , Middle Aged , Time FactorsABSTRACT
Thirty patients of medium (47 +/- 3) years of age with prosthetic bileaflet heart valves without any specific complications of the I-II functional classes and with the postoperative period after mitral (11) and aortal (19) valve replacements during (2.52 +/- 0.48) years were studied. The defects of coagulation and fibrinolytic systems were found in 9 patients with high prothrombin index (93.21 +/- 9.8)% and low INR (0.9-1.7). The activation of fibrinolysis, low platelets, hypofibrinogenemia, D-dimer which are the risk factors of thrombogenic complications were found in these patients. The updated turbo-dynamic express-method which helps to activate fibrinolysis in short terms and to make its correction is proposed.
